24 April 2020 : Meta-Analysis
Comparative Effectiveness of Tadalafil versus Tamsulosin in Treating Lower Urinary Tract Symptoms Suggestive of Benign Prostate Hyperplasia: A Meta-Analysis of Randomized Controlled Trials
Boda Guo1ADE, Xin Chen2ADE, Miao Wang2B, Huimin Hou2C, Zhipeng Zhang2F, Ming Liu1G*DOI: 10.12659/MSM.923179
Med Sci Monit 2020; 26:e923179
Abstract
BACKGROUND: Evidence directly evaluating the efficacy of tadalafil vs. tamsulosin for lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH) is limited. We performed a meta-analysis of published studies to assess the comparative effectiveness of tadalafil vs. tamsulosin in treating LUTS suggestive of BPH.
MATERIAL AND METHODS: After performing a comprehensive publication search with PubMed, EMBASE, and Cochrane Controlled Trials Register using the search terms “tadalafil”, “tamsulosin”, “lower urinary tract symptoms”, and “controlled”, 335 articles were screened, out of which 7 randomized controlled trials published up to July 2019 were identified and included in this meta-analysis review.
RESULTS: From 335 screened articles, 7 studies (totalling 1601 patients) were finally included in our analysis. There was no statistically significant difference between tadalafil and tamsulosin in improving the clinical outcomes of total International Prostate Symptom Score (IPSS),voiding subscores, storage subscores, quality of life (QoL) scores, maximum flow rate (Qmax), and postvoid residual urine (PVR), but a statistically significant difference was observed in the International Index of Erectile Function scores (IIEF scores).
CONCLUSIONS: Tadalafil and tamsulosin have similar effects in managing LUTS secondary to BPH. Tadalafil is superior to tamsulosin in treating LUTS suggestive of BPH when associated with erectile dysfunction (ED).
Keywords: Adrenergic alpha-1 Receptor Antagonists, Lower urinary tract symptoms, Phosphodiesterase 5 Inhibitors, Prostatic Hyperplasia, Double-Blind Method, Drug Therapy, Combination, Hyperplasia, Quality of Life, tadalafil, tamsulosin
Editorial
01 December 2024 : Editorial
Editorial: The 2024 Revision of the Declaration of Helsinki and its Continued Role as a Code of Ethics to Guide Medical ResearchDOI: 10.12659/MSM.947428
Med Sci Monit 2024; 30:e947428
In Press
Clinical Research
Comparative Efficacy of Unilateral Biportal Endoscopy vs Traditional Surgery in Lumbar Degenerative DisordersMed Sci Monit In Press; DOI: 10.12659/MSM.946468
Clinical Research
Association Between Pre-Pregnancy Body Mass Index and Labor Induction Success Rates: A Case Control StudyMed Sci Monit In Press; DOI: 10.12659/MSM.946357
Clinical Research
Emotional Labor of Caregivers of Elderly Patients with Dementia and Disabilities in a Psychiatric Hospital ...Med Sci Monit In Press; DOI: 10.12659/MSM.945722
Clinical Research
Evaluation of Perceived Stress and Its Association with Dental Caries in 290 Undergraduate Medical StudentsMed Sci Monit In Press; DOI: 10.12659/MSM.946528
Most Viewed Current Articles
17 Jan 2024 : Review article 6,957,863
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research 1,970,100
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 697,487
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
07 Jan 2022 : Meta-Analysis 263,461
Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...DOI :10.12659/MSM.935074
Med Sci Monit 2022; 28:e935074